OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Improving these processes involves fine-tuning various parameters, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to maximize antibody yield while lowering production co